Trends in the development of remdesivir based inventions against COVID-19 and other disorders: A patent review
出版年份 2021 全文链接
标题
Trends in the development of remdesivir based inventions against COVID-19 and other disorders: A patent review
作者
关键词
Remdesivir, COVID-19, Patent, Composition, Combination, Delivery system, New indication
出版物
Journal of Infection and Public Health
Volume 14, Issue 8, Pages 1075-1086
出版商
Elsevier BV
发表日期
2021-06-27
DOI
10.1016/j.jiph.2021.06.013
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- SARS-CoV-2 RNA dependent RNA polymerase as a therapeutic target for COVID-19
- (2021) Ilaria Vicenti et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- COVID-19: Characteristics and Therapeutics
- (2021) Rameswari Chilamakuri et al. Cells
- Coronavirus helicases: attractive and unique targets of antiviral drug-development and therapeutic patents
- (2021) Austin N. Spratt et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- COVID-19 Fundamentals
- (2021) Flavia Lamberghini et al. JOURNAL OF THE AMERICAN DENTAL ASSOCIATION
- Pharmacogenetics Approach for the Improvement of COVID-19 Treatment
- (2021) Ingrid Fricke-Galindo et al. Viruses-Basel
- Recent knowledge in favor of remdesivir (GS-5734) as a therapeutic option for the COVID-19 infections
- (2021) S. Saqrane et al. Journal of Infection and Public Health
- Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor
- (2021) Rita Humeniuk et al. CLINICAL PHARMACOKINETICS
- COVID-19 vaccine challenges: What have we learned so far and what remains to be done?
- (2021) Rebecca Forman et al. HEALTH POLICY
- Facing coronavirus disease 2019: What do we know so far? (Review)
- (2021) Qie Guo et al. Experimental and Therapeutic Medicine
- Wuhan to World: The COVID-19 Pandemic
- (2021) Ashok Kumar et al. Frontiers in Cellular and Infection Microbiology
- Challenges in reported COVID-19 data: best practices and recommendations for future epidemics
- (2021) Rinette Badker et al. BMJ Global Health
- SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review
- (2020) José Adão Carvalho Nascimento Junior et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
- (2020) Calvin J. Gordon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19
- (2020) Richard T. Eastman et al. ACS Central Science
- Remdesivir against COVID-19 and Other Viral Diseases
- (2020) Jakob J. Malin et al. CLINICAL MICROBIOLOGY REVIEWS
- Inhibitors of type II transmembrane serine proteases in the treatment of diseases of the respiratory tract – A review of patent literature
- (2020) Alexandre Murza et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Protease inhibitors targeting the main protease and papain-like protease of coronaviruses
- (2020) Clemente Capasso et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Recent progress in drug delivery
- (2019) Chong Li et al. Acta Pharmaceutica Sinica B
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started